Literature DB >> 23598479

Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.

Sonia Pagliusi1, Luciana C C Leite, Mahima Datla, Morena Makhoana, Yongzhong Gao, Mahendra Suhardono, Suresh Jadhav, Gutla V J A Harshavardhan, Akira Homma.   

Abstract

The Developing Countries Vaccine Manufacturers Network (DCVMN) is a unique model of a public and private international alliance. It assembles governmental and private organizations to work toward a common goal of manufacturing and supplying high-quality vaccines at affordable prices to protect people around the world from known and emerging infectious diseases. Together, this group of manufacturers has decades of experience in manufacturing vaccines, with technologies, know-how, and capacity to produce more than 40 vaccines types. These manufacturers have already contributed more than 30 vaccines in various presentations that have been prequalified by the World Health Organization for use by global immunization programmes. Furthermore, more than 45 vaccines are in the pipeline. Recent areas of focus include vaccines to protect against rotavirus, human papillomavirus (HPV), Japanese encephalitis, meningitis, hepatitis E, poliovirus, influenza, and pertussis, as well as combined pentavalent vaccines for children. The network has a growing number of manufacturers that produce a growing number of products to supply the growing demand for vaccines in developing countries.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598479     DOI: 10.1016/j.vaccine.2012.11.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Vaccines against poverty.

Authors:  Calman A MacLennan; Allan Saul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 2.  Enhancing vaccine safety capacity globally: A lifecycle perspective.

Authors:  Robert T Chen; Tom T Shimabukuro; David B Martin; Patrick L F Zuber; Daniel M Weibel; Miriam Sturkenboom
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

Review 3.  Vaccine development for emerging infectious diseases.

Authors:  Jean-Louis Excler; Melanie Saville; Seth Berkley; Jerome H Kim
Journal:  Nat Med       Date:  2021-04-12       Impact factor: 53.440

Review 4.  Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.

Authors:  Emma Rey-Jurado; Felipe Tapia; Natalia Muñoz-Durango; Margarita K Lay; Leandro J Carreño; Claudia A Riedel; Susan M Bueno; Yvonne Genzel; Alexis M Kalergis
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

5.  Delay in Vaccine Access in ASEAN Countries.

Authors:  Nilubon Subsittipong; Junjeong Choi; Tae Hyun Kim; Euna Han
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390

Review 6.  Vaccines against invasive Salmonella disease: current status and future directions.

Authors:  Calman A MacLennan; Laura B Martin; Francesca Micoli
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

7.  Emerging vaccine manufacturers are innovating for the next decade.

Authors:  Benoit Hayman; Sonia Pagliusi
Journal:  Vaccine X       Date:  2020-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.